Page last updated: 2024-10-18

dalteparin and Ambulation Difficulty

dalteparin has been researched along with Ambulation Difficulty in 9 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
" Initial studies of extended thromboprophylaxis in acutely ill medical patients with enoxaparin, rivaroxaban and apixaban showed little to no benefit towards VTE reduction that was consistently outweighed by increased bleeding."4.98Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis. ( Burnett, AE; Fletcher, ML; Mahan, CE; Spyropoulos, AC, 2018)
"The risk of venous thromboembolism is equally high in medical patients admitted to the hospital and those treated in the surgery wards."2.73[Two models of thromboprophylaxis in acutely ill medical inpatients]. ( Firek, A; Kochanowski, Z; Luba, M, 2007)
"Calf deep vein thrombosis (CDVT) is frequently found in symptomatic outpatients, but CDVT ultrasound diagnostic criteria are still debated."1.43Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment. ( Cosmi, B; Favaretto, E; Ghirarduzzi, A; Giusto, L; Iotti, M; Lessiani, G; Migliaccio, L; Palareti, G; Sartori, M, 2016)
"Major bleedings were reported as secondary endpoints in only two hospitalized patients."1.35[Prophylaxis of deep vein thrombosis with enoxaparin 40 mg in outpatients compared to hospitalized medically ill patients]. ( Kröger, K, 2009)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Luba, M1
Firek, A1
Kochanowski, Z1
Mahan, CE1
Burnett, AE1
Fletcher, ML1
Spyropoulos, AC1
Ageno, W1
Di Minno, G1
Agnelli, G1
Cimminiello, C1
Imberti, D1
Polo Friz, H1
Prandoni, P1
Scaglione, F1
Martí-Gamboa, S1
Savirón Cornudella, R1
Campillos-Maza, JM1
Sartori, M1
Lessiani, G1
Favaretto, E1
Migliaccio, L1
Iotti, M1
Giusto, L1
Ghirarduzzi, A1
Palareti, G1
Cosmi, B1
Ahuja, RB1
Bansal, P1
Pradhan, GS1
Subberwal, M1
Kröger, K1
Kent, DM1
Lindenauer, PK1
Hull, RD1
Schellong, SM1
Tapson, VF1
Monreal, M1
Samama, MM1
Turpie, AG1
Wildgoose, P1
Yusen, RD1

Reviews

2 reviews available for dalteparin and Ambulation Difficulty

ArticleYear
Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Hospital practice (1995), 2018, Volume: 46, Issue:1

    Topics: Age Factors; Anticoagulants; Benzamides; Drug Administration Schedule; Enoxaparin; Hemorrhage; Hospi

2018
[Massive gestational vulvar edema. A case report and review of literature].
    Ginecologia y obstetricia de Mexico, 2014, Volume: 82, Issue:9

    Topics: Albumins; Anti-Infective Agents; Anticoagulants; Cesarean Section; Edema; Enoxaparin; Exudates and T

2014

Trials

3 trials available for dalteparin and Ambulation Difficulty

ArticleYear
[Two models of thromboprophylaxis in acutely ill medical inpatients].
    Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:4

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anticoagulants; Double-Blind Method; Feasibility Stud

2007
An analysis of deep vein thrombosis in burn patients (part II): A randomized and controlled study of thrombo-prophylaxis with low molecular weight heparin.
    Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:8

    Topics: Adolescent; Adult; Body Surface Area; Burns; Disease Management; Enoxaparin; Epistaxis; Female; Fibr

2016
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.
    Journal of thrombosis and thrombolysis, 2006, Volume: 22, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Double-Blind Method; Enoxaparin; Female; Humans; Mal

2006

Other Studies

4 other studies available for dalteparin and Ambulation Difficulty

ArticleYear
A survey on the views and attitudes of Italian physicians regarding the prophylaxis and treatment of venous thromboembolism.
    Minerva medica, 2020, Volume: 111, Issue:4

    Topics: Anticoagulants; Attitude of Health Personnel; Contraindications, Drug; Enoxaparin; Health Care Surve

2020
Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2016, Volume: 52, Issue:5

    Topics: Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Area Under Curve; Enoxaparin; Female; Huma

2016
[Prophylaxis of deep vein thrombosis with enoxaparin 40 mg in outpatients compared to hospitalized medically ill patients].
    Medizinische Klinik (Munich, Germany : 1983), 2009, Volume: 104, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Cross-Sectional Studies; Enoxaparin

2009
Aggregating and disaggregating patients in clinical trials and their subgroup analyses.
    Annals of internal medicine, 2010, Jul-06, Volume: 153, Issue:1

    Topics: Acute Disease; Anticoagulants; Data Interpretation, Statistical; Delayed-Action Preparations; Enoxap

2010